| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/10/2008 | CA2656170A1 Infant formulas for early brain development |
| 01/10/2008 | CA2656131A1 Pharmaceutical composition containing a tetrahydrofolic acid |
| 01/10/2008 | CA2656128A1 Process for the preparation of enantiomerically pure salts of n-methyl-3(1-naphthaleneoxy)-3-(2-thienyl)propanamine |
| 01/10/2008 | CA2656126A1 Polymorphic form of duloxetine hydrochloride |
| 01/10/2008 | CA2656087A1 Sugar-free storage-stable antihistaminic syrups |
| 01/10/2008 | CA2656045A1 Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics |
| 01/10/2008 | CA2655947A1 Compositions comprising nkt cell agonist compounds and methods of use |
| 01/10/2008 | CA2655860A1 Method for the eradication of pathogens indluding s. aureus and antibiotic resistant microbes from the upper respiratory tract of mammals and for inhibiting the activation of immune cells |
| 01/10/2008 | CA2655720A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 01/10/2008 | CA2655713A1 Derivatives of imidazo[1,2-.alpha.]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 01/10/2008 | CA2655680A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
| 01/10/2008 | CA2655675A1 Substituted n-phenylmethyl -5-oxo-proline-2-amides as p2x7-receptor antagonists and their methods of use |
| 01/10/2008 | CA2655633A1 New pyridine analogues |
| 01/10/2008 | CA2655629A1 New pyridine analogues |
| 01/10/2008 | CA2655628A1 New pyridine analogues |
| 01/10/2008 | CA2655552A1 Use of 2-benzoyl-imidazopyridines in therapeutics |
| 01/10/2008 | CA2654902A1 Solid compositions comprising tadalafil and at least one carrier |
| 01/10/2008 | CA2654666A1 Pharmaceutical compositions |
| 01/10/2008 | CA2654529A1 Compositions with controlled pharmacokinetics |
| 01/10/2008 | CA2654525A1 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant |
| 01/10/2008 | CA2654523A1 Pharmaceutical compositions of memantine |
| 01/10/2008 | CA2654383A1 Pharmaceutical compositions of ropinirole and methods of use thereof |
| 01/10/2008 | CA2654246A1 Benzimidazole cannabinoid agonists bearing a substituted heterocyclic group |
| 01/10/2008 | CA2650433A1 Method of treatment of hereditary hemochromatosis |
| 01/10/2008 | CA2648782A1 Method for administering tolperisone |
| 01/10/2008 | CA2648520A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1876238A1 Novel polypeptide and use thereof |
| 01/09/2008 | EP1876187A1 Preparation of multinuclear ferric-saccharidic complexes |
| 01/09/2008 | EP1876180A2 Semi-synthetic ecteinascidins |
| 01/09/2008 | EP1876179A1 Thienopyrimidone compound |
| 01/09/2008 | EP1876178A1 Cyanopyridine derivative and use thereof as medicine |
| 01/09/2008 | EP1876175A1 Therapeutic agent for corneal disease |
| 01/09/2008 | EP1876174A1 Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1876169A1 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 01/09/2008 | EP1876167A1 Crystal polymorphism of 4 -{2-ý(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino¨ethoxy}-3-isopropyl-3 ,5 -dimethylbiphenylcarboxylic acid hydrochloride |
| 01/09/2008 | EP1875928A1 Novel method of using triacetin and auxiliary agent for ultrasonic diagnostic examination |
| 01/09/2008 | EP1875926A1 Stable emulsion composition |
| 01/09/2008 | EP1875925A1 Preventive or remedy for bowel disease |
| 01/09/2008 | EP1875922A2 Intestinal trefoil proteins |
| 01/09/2008 | EP1875919A1 Artificial cerebrospinal fluid |
| 01/09/2008 | EP1875917A2 Use of NO for the treatment or prevention of reversible pulmonary vasoconstriction |
| 01/09/2008 | EP1875916A2 Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate |
| 01/09/2008 | EP1875915A1 Therapeutic agent for chronic obstructive pulmonary disease |
| 01/09/2008 | EP1875914A1 Solid compositions comprising tadalafil and at least one carrier |
| 01/09/2008 | EP1875913A1 Compositions and method for treating infection in cattle and swine |
| 01/09/2008 | EP1875912A1 Agent for treating involuntary movement |
| 01/09/2008 | EP1875911A1 Stabilized composition |
| 01/09/2008 | EP1875910A1 Application of levo-ornidazole in preparation of anti-anaerobic bacteria infection medicine |
| 01/09/2008 | EP1875909A2 Use of antagonists of PYY receptors for treating irritable bowel syndrome |
| 01/09/2008 | EP1875908A1 Use of Chrysin |
| 01/09/2008 | EP1875907A2 Use of yessotoxins in the treatment of allergic and asthmatic processes |
| 01/09/2008 | EP1875906A2 Therapeutic use of yessotoxins as human tumor cell growth inhibitors |
| 01/09/2008 | EP1875905A2 Pharmaceutical compound in the form of a hydrogel for transdermal application of active substances |
| 01/09/2008 | EP1875904A1 Methods |
| 01/09/2008 | EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives |
| 01/09/2008 | EP1875902A1 Sedative effect-providing agent and sedative fragrance composition containing the same |
| 01/09/2008 | EP1875901A1 Propofol-containing fat emulsion |
| 01/09/2008 | EP1875900A2 JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis |
| 01/09/2008 | EP1875899A1 Use of 5HT7 receptor agonists for the treatment of pain |
| 01/09/2008 | EP1875898A2 Transdermal patch for administering fentanyl |
| 01/09/2008 | EP1875896A1 Solubilisation formulation |
| 01/09/2008 | EP1875894A2 Use of at least one C-glycoside derivative as a soothing agent |
| 01/09/2008 | EP1875816A2 Beverages with specialized supplements |
| 01/09/2008 | EP1874821A1 Combination of antibodies and glucocorticoids for treating cancer |
| 01/09/2008 | EP1874795A1 Compositions and uses of amooranin compounds |
| 01/09/2008 | EP1874790A2 New s-adenosyl-l-methionine analogs with extended activated groups for transfer by methyltransferases |
| 01/09/2008 | EP1874789A1 Fluorinated 3'-deoxythymidine derivatives, a method for their preparation and their use |
| 01/09/2008 | EP1874788A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents |
| 01/09/2008 | EP1874787A1 Glucopyranosyl-substituted (heteroaryloxy-benzyl)-benzene derivatives as sglt inhibitors |
| 01/09/2008 | EP1874783A1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 01/09/2008 | EP1874782A1 Oxazolidinone derivatives as antimicrobials |
| 01/09/2008 | EP1874781A1 Dihydrothienopyrimidines for the treatment of inflammatory diseases |
| 01/09/2008 | EP1874780A1 4-piperazinylthieno[2,3-d]pyrimidine compounds as platelet aggregation inhibitors |
| 01/09/2008 | EP1874778A1 Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-n-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein |
| 01/09/2008 | EP1874777A1 H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use |
| 01/09/2008 | EP1874776A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders |
| 01/09/2008 | EP1874775A2 Triazolophthalazines as pde2-inhibitors |
| 01/09/2008 | EP1874774A1 Combination product |
| 01/09/2008 | EP1874772A1 Purine and imidazopyridine derivatives for immunosuppression |
| 01/09/2008 | EP1874770A1 Phenylacetamides suitable as protein kinase inhibitors |
| 01/09/2008 | EP1874769A1 Novel aza- heterocycles serving as kinase inhibitors |
| 01/09/2008 | EP1874768A2 Inhibitors of akt activity |
| 01/09/2008 | EP1874766A2 Crystalline form of a quinolinone-carboxamide compound |
| 01/09/2008 | EP1874764A2 Imino-oxazolidines and use thereof as anticoagulants |
| 01/09/2008 | EP1874763A2 Polymorph form ii of tanaproget |
| 01/09/2008 | EP1874759A1 C-met modulators and methods of use |
| 01/09/2008 | EP1874756A1 Chromane and chromene derivatives and uses thereof |
| 01/09/2008 | EP1874755A2 Benzothiophene hydroxamic acid derivatives |
| 01/09/2008 | EP1874754A1 Pure duloxetine hydrochloride |
| 01/09/2008 | EP1874750A1 Dihydrobenzofuranyl alkanamine derivatives as 5ht2c agonists |
| 01/09/2008 | EP1874749A1 FURAN COMPOUNDS USEFUL AS EPl RECEPTOR ANTAGONISTS |
| 01/09/2008 | EP1874748A1 2 -aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitor (iap) modulators |
| 01/09/2008 | EP1874747A1 Histamine h3-recept0r ligands and their therapeutic application |
| 01/09/2008 | EP1874746A2 Novel histamine h3-receptor ligands and their therapeutic applications |
| 01/09/2008 | EP1874745A1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands |
| 01/09/2008 | EP1874743A2 Purified form of tanaproget |
| 01/09/2008 | EP1874741A1 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 01/09/2008 | EP1874739A1 Pharmaceutically active diazepanes |